Raphael Pharmaceutical Inc. Shareholders' Equity
Raphael Pharmaceutical Inc. (RAPH) had Shareholders' Equity of -$1.89 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$1.89M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.66M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.43M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$1.26M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$1.89M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$1.66M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$1.43M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$1.26M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$1.05M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$734.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$742.00K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$616.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$290.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | -$103.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $107.00K 10-K · filed 2026-03-31 | -$267.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | -$75.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$61.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$9.00K 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $106.00K 10-K · filed 2025-03-31 | |
| 2022-09-30 | -$62.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $118.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $103.00K 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $128.00K 10-K · filed 2024-03-28 | |
| 2021-09-30 | -$125.00K 10-Q · filed 2021-11-16 | |
| 2021-06-30 | $191.00K 10-Q · filed 2021-11-16 | |
| 2020-12-31 | -$43.00K 10-K/A · filed 2023-05-25 | |
| 2020-09-30 | -$280.00K 10-Q · filed 2021-11-16 | |
| 2020-06-30 | -$37.00K 10-Q · filed 2021-11-16 | |
| 2019-12-31 | $208.00K 10-Q · filed 2021-11-16 |